Thursday's Analysts' Upgrades and Downgrades
Intercontinental Exchange (ICE Quote) estimates cut at Goldman: 2008 estimates on ICE reduced to $5.40 from $5.53 at Goldman. Q4 results came in 2 cents below Goldman expectations. Key negative was declining rate per contract in futures. Positives include pent-up demand by algorithmic traders for OTC and NYBOT products and management's focus on non-organic growth initiatives. Maintained Buy rating.
Lazard (LAZ Quote) price target raised at Goldman: Goldman is upping its target on LAZ to $63 from $58 following strong earnings beat in Q4 results. See strong results in advisory and asset management incentive fees. 2007 estimates raised to $2.75 from $2.65. Maintained Buy rating. Loopnet (LOOP Quote) estimates raised at Credit Suisse: Credit Suisse is raising its 2007 EPS estimates on LOOP to 40 cents from 36 cents following strong Q4 results. Raised target price to $19 from $18. MedImmune (MEDI Quote) estimates slashed at Goldman: 2006 estimates on MEDI cut to $0.09 from $0.20 at Goldman. See concerns over Synagis and delay in FDA filing of Numax to the second half of 2007. Maintained Buy rating and $37 target. XL Capital (XL Quote) estimates cut at Goldman: Goldman is reducing its 2007 estimates on XL by $0.50 to $8.80, due to management guidance for Financial Operations and Investment Affiliates income that was lower than forecasts. Maintained Neutral rating and $85 target.- Loading Comments...
- Loading Comments...
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,316.95 | 1,101.87 | 2,170.99 | 34.74 |
Oil *
78.34
|
|
UP
69.98
|
UP
8.86
|
UP
19.91
|
DOWN
0.08
|
10 Yr
3.47%
SPDR Gold
109.47
|
|
+0.68%
|
+0.81%
|
+0.93%
|
-0.23%
|
Data delayed 20 minutes |














